Michael Scolaro

Michael Scolaro

Nov 10, 2017

Group 6 Copy 245
1
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

Developing a low-cost, rapid diagnostic for urogenital Schistosomiasis infection

We are developing a frugal diagnostic for urogenital schistosomiasis, a neglected tropical disease that...

Part 2: Can low carbohydrate ketogenic diets inhibit cancers?

We've identified that ketone bodies, i.e. fuels in the bloodstream that result from a very low carbohydrate...

How does involvement in kink, fetish or BDSM impact a person's health?

Kink-involved people engage in atypical erotic activities such as bondage, rough sex, and fetish activities...

Backer Badge Funded